Title of cohort


Patterns of multimorbidity in primary health care - a prospective observational study

Acronym for cohort


Multicare1

Name of Principal Investigator - Title


Prof

Name of Principal Investigator - First name


Hendrik

Name of Principal Investigator - Last name


van den Bussche

Address of institution -Institution


Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf

Address of institution - Street address


Martinistr. 52

Address of institution - City


Hamburg

Address of institution - Postcode


20246

Country


Germany

Website


www.uke.de/institute/allgemeinmedizin/index_46738.php

Contact email


[email protected]

Funding source


Q1a. Please indicate below if your cohort includes or expects to include, incidence of the following conditions?


Alzheimer's disease and other dementias| Parkinson's disease

Q1b. When are studies on the above condition(s) expected to become possible?


Q2a. In a single sentence what is the stated aim of the cohort?


To identify prognostic variables for the course of multimorbidity, and to describe the severity and the somatic and psychosocial long-term consequences of multimorbidity patterns as well as health care utilization

Q2b. What distinguishes this cohort from other population cohorts?


Q3a. i) Number of publications that involve use of your cohort to date


0

Q3a.ii) Please give up to three examples of studies to date (Principal Investigator, Institution, Title of Study)


Q3b. If data on research outputs are already available please paste the publication list/other data or provide a link to where these data are publicly available


Q3c. If no research has been done as yet, please explain in a few sentences what information (i.e. research findings) you expect will be gained from the population


Q4a. Study criteria: what is the age range of participants at recruitment? Age in years From:


65

Q4a. Study criteria: what is the age range of participants at recruitment? To:


84

Q4b. Study criteria: what are the inclusion criteria?


1. age of 65 to 84 years at baseline, 2. consultation of the GP at least once within the last completed quarter, 3. at least 3 chronic conditions out of a list of 29 diseases/syndromes

Q4c. Study criteria: what are the exclusion criteria?


1. residence in a nursing home, 2. severe illness probably lethal within three months according to the GP, 3. insufficient ability to speak and read German, insufficient ability to consent (e.g. dementia), 4. insufficient ability to participate in interviews (e.g. blindness, deafness), 5. poorly known patients to the GP because of accidental consultation 6. participation in other studies at the present time

Q5. What is the size of the cohort (i.e. how many participants have enrolled)?


1,000-5,000 participants

Q6a. Please describe what measures are used to characterise participants


Age, gender, migrant status, marital status, household type and size, education, former occupation, income, wealth, morbidity, activities of daily living, motor skills, vision and hearing, cognitive impairment, pain, health-related quality of life, body mass index, waist-to-hip-ratio, physical activity, nutrition, alcohol use, smoking behaviour, general self-efficacy, coping with illness, social support, patient assessment of chronic illness care, utilization of medical services, medication, mortality

Q6b. Are there additional measures for participants with a clinical disorder?


Q6c. Are there defined primary and secondary endpoints (e.g. defined health parameters)?


No

If yes please specify


Q7. What is the study design (select all that apply)?


Prospective cohort

Q8. Are your cases matched by


Q9a. Does your study include a specialised subset of control participants?


Q9b. If your study includes a specialised subset of control participants please describe


Q10a. i) Please enter the data collection start date


01/07/2008

Q10a. ii) Please enter the data collection end date


Q10a. iii) Is data collection for this study


Data collection ongoing| Data analysis ongoing| Data collection ongoing| Data analysis ongoing

Q10b. If data collection is ongoing, are there plans to continue the cohort study beyond the current projected end date?


Yes - intend to apply for funding

Q11. Is data collected


Other please specify here


Q12. Is there a system in place to enable re-contact with patients to ask about participation in future studies?


Q13a. Please give information on the format and availability of data stored in a database (1)


% available


Q13a. Please give information on the format and availability of data stored in a database (2)


% available


Q13a. Please give information on the format and availability of data stored in a database (3)


% available


Q13a. Please give information on the format and availability of data stored in a database (4)


% available


Other (please specify)


% available


Q13b. Please give information on the format and availability of data held as individual records (1)


% available


Q13b. Please give information on the format and availability of data held as individual records (2)


% available


Q13b. Please give information on the format and availability of data held as individual records (3)


% available


Q13b. Please give information on the format and availability of data held as individual records (4)


% available


Please specify language used


Q14a. Is data available to other groups?


No

Q14b. If data is available to other groups what is the access policy/mechanisms for access?


Q15. What data sharing policy is specified as a condition of use?


No policy exists

Q16a. Are tissues/samples/DNA available to other groups?


No

Q16b i) If yes, please describe below:


Q16b. ii) In what form are tissues/samples/DNA supplied?


Q16b. iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data (Q14 above)?


Q17. Is information on biological characteristics available to other groups?


No

Number of Patients


% of total cohort

Export as PDF